Form S-3 Talphera Inc For: 13 November
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Talphera Inc (TLPH)
Talphera Inc stock price live, this page displays NASDAQ TLPH stock exchange data. View the TLPH premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Talphera Inc real time stock price chart below.
What Is the Talphera Inc Stock Price Today?
The Talphera Inc stock price today is 0.9060.
What Is the Stock Symbol for Talphera Inc?
The stock symbol for Talphera Inc is "TLPH."
What Stock Exchange Does Talphera Inc Trade On?
Talphera Inc is listed and trades on the NASDAQ stock exchange.
Is Talphera Inc a Good Stock to Buy?
Determining whether Talphera Inc, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TLPH quote. (ISIN: US00444T2096)
What Is the Talphera Inc Stock Price Today?
The Talphera Inc stock price today is 0.9060.
What Is the Stock Symbol for Talphera Inc?
The stock symbol for Talphera Inc is "TLPH."
What Stock Exchange Does Talphera Inc Trade On?
Talphera Inc is listed and trades on the NASDAQ stock exchange.
Is Talphera Inc a Good Stock to Buy?
Determining whether Talphera Inc, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TLPH quote. (ISIN: US00444T2096)
Fair Value
An estimate of a Talphera's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.7700
1.0100
52 wk Range
0.6866
1.5700
Unusual Post-Market activity
1/2
Fair Value
An estimate of a Talphera's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.77001.0100
52 wk Range
0.68661.5700
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
TLPH Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Talphera's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
3.1250
Upside
+244.92%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales decline in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 3.1250
(+244.92% Upside)
Talphera Inc Earnings Call Summary for Q3/2026
- Talphera posted Q3 2026 EPS of -$0.05, beating consensus of -$0.07 by 28.57%; shares surged 10.35% after-hours to $1.1421.
- NEPHRO-CRRT study enrollment exceeded 75% of target; company requested FDA Sprint Meeting for potential early closure with response expected by year-end.
- Management projects $14.2M cash plus ~$16M conditional financing will fund operations through potential 2027 PMA approval for Niyad anticoagulant.
- Peak annual U.S. sales estimate for Niyad in CRRT raised to over $200M; investor event planned for Q1 2027 to detail commercial opportunity.
- Operating expenses rose 15.2% YoY to $3.8M for development and pre-launch activities; top-line data expected 4-6 weeks post-enrollment closure.
Last Updated: 12/11/2026, 23:18
Read Full TranscriptEarnings
Latest Release
Nov 12, 2026
EPS / Forecast
-0.05 / -0.07
Revenue / Forecast
-- / --
Compare TLPH to Peers and Sector
Metrics to compare | TLPH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTLPHPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.2x | −3.8x | −0.2x | |
PEG Ratio | −0.08 | −0.15 | 0.00 | |
Price/Book | 4.4x | 1.8x | 2.6x | |
Price / LTM Sales | - | 11.6x | 2.8x | |
Upside (Analyst Target) | 244.9% | 122.0% | 65.0% | |
Fair Value Upside | Unlock | −10.4% | 9.6% | Unlock |
Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company’s lead product candidate, Niyad, is a lyophilized formulation of nafamostat that acts as a regional anticoagulant for infusion into the extracorporeal circuit. It is also developing LTX-608, a lyophilized vial containing nafamostat for IV infusion for disseminated intravascular coagulation, acute respiratory distress syndrome, acute pancreatitis, and an anti-viral treatment; Fedsyra, an ephedrine pre-filled syringe for injection; and a phenylephrine pre-filled syringe for injection. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is headquartered in San Mateo, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Talphera (TLPH) Stock Price Today?
The Talphera stock price today is 0.9060 USD.
What Stock Exchange Does Talphera Trade On?
Talphera is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Talphera?
The stock symbol for Talphera is "TLPH."
What Is the Talphera (TLPH) Afterhours Price Today? (Afterhours variable test: 0.8400) Current Date: Nov 14, 2026
After hours price: 0.8400. After hours price change (units): -0.0660. Price change percentage: -7.2800%
What Is the Talphera Market Cap?
As of today, Talphera market cap is 53.7200M USD.
What Is Talphera's Earnings Per Share (TTM)?
The Talphera EPS (TTM) is -0.20.
When Is the Next Talphera Earnings Date?
Talphera will release its next earnings report on Mar 11, 2027.
From a Technical Analysis Perspective, Is TLPH a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Talphera Stock Split?
Talphera has split 1 times.
How Many Employees Does Talphera Have?
Talphera has 12 employees.
What is the current trading status of Talphera (TLPH)?
As of Nov 14, 2026, Talphera (TLPH) is trading at a price of 0.9060 USD, with a previous close of 1.0350 USD. The stock has fluctuated within a day range of 0.7700 USD to 1.0100 USD, while its 52-week range spans from 0.6866 USD to 1.5700 USD.
What Is Talphera (TLPH) Price Target According to Analysts?
The average 12-month price target for Talphera is 3.1250 USD, with a high estimate of 3.5 USD and a low estimate of 3 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +244.92% Upside potential.
What Is the TLPH Premarket Price?
TLPH's last pre-market stock price is 1.0323 USD. The pre-market share volume is 23,790.0000, and the stock has decreased by -0.0027, or -0.2600%.
What Is the TLPH After Hours Price?
TLPH's last after hours stock price is 0.8400 USD, the stock has decreased by -0.0660, or -7.2800%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.